EW
XLRN

Evoke Wealth’s Acceleron Pharma XLRN Stock Holding History

Evoke Wealth’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-20
Closed -$3K – 1266
2021
Q3 		$3K Hold
20
– – ﹤0.01% 981
2021
Q2 		$3K Hold
20
– – ﹤0.01% 1021
2021
Q1 		$3K Hold
20
– – ﹤0.01% 994
2020
Q4 		$3K Hold
20
– – ﹤0.01% 856
2020
Q3 		$2K Hold
20
– – ﹤0.01% 886
2020
Q2 		$2K Buy
+20
New +$1.93K ﹤0.01% 926

Evoke Wealth's XLRN Position: Q4 2021 in Review

Evoke Wealth sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 20 shares — an estimated $3K sold.

Evoke Wealth first reported a position in XLRN in Q2 2020 and held it in 6 quarters. The position peaked at $3K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Evoke Wealth reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Evoke Wealth sold 20 Acceleron Pharma shares in Q4 2021, an estimated $3K.
  • Evoke Wealth first reported a position in Acceleron Pharma in Q2 2020 and held it in 6 quarters.
  • Evoke Wealth's Acceleron Pharma position peaked at $3K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Evoke Wealth's 13F filing for Q4 2021, filed 9 Feb 2022.